Solving COVID: May 27, 2020
Encouraging news about coronavirus antibodies, another vaccine starts human trials, and more
- 1. French study bolsters hopes antibodies protect against COVID-19
- 2. Human trials begin for Novavax's coronavirus vaccine
- 3. AstraZeneca gets orders for COVID-19 vaccine it's developing
- 4. Experts seek 'technical breakthrough' in scramble for rapid coronavirus tests
- 5. CRISPR gene-editing tool could diagnose COVID-19 in 20 minutes
1. French study bolsters hopes antibodies protect against COVID-19
Researchers at France's Pasteur Institute and university hospitals in Strasbourg said Tuesday that in a study of 160 doctors and nurses who experienced mild cases of COVID-19, all but one developed antibodies within two weeks that could prevent reinfection. The preliminary findings, not yet peer-reviewed, bolstered hopes that patients who survive the new coronavirus, even if they never got seriously ill, would be protected. Almost all of the volunteers in the study had produced antibodies capable of neutralizing the virus — or preventing it from replicating — within 41 days. Pasteur's Arnaud Fontanet and his colleagues suggested the findings support the use of antibody tests.
2. Human trials begin for Novavax's coronavirus vaccine
Biotechnology company Novavax rolled out its first human trials for its coronavirus vaccine on Tuesday. Novavax already tested its vaccine on animals in low doses and found it successful. The Maryland-based company will inject 131 volunteers in the Australian cities of Melbourne and Brisbane, with results of the clinical trial expected to be made public in July. Phase 1 of the trial is a "randomized, observer-blinded, placebo-controlled trial" that assesses two different dosage sizes of the vaccine among healthy participants age 18 to 59. Novavax is one of several pharmaceutical companies racing to develop coronavirus vaccines, with Pfizer and Moderna launching human trials earlier this month.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
3. AstraZeneca gets orders for COVID-19 vaccine it's developing
Anglo-Swedish drug maker AstraZeneca sealed its first agreements to provide 400 doses of the COVID-19 vaccine it is developing. The company said it had received more than $1 billion from the U.S. Biomedical Advanced Research and Development Authority for getting the vaccine produced and delivered starting in the fall. AstraZeneca CEO Pascal Soriot said the investment by the U.S. vaccine agency would help speed up development of the vaccine. The company and other drug makers, including Moderna and Sanofi, are racing to develop vaccines that public health officials say are necessary for removing restrictions imposed to contain the coronavirus pandemic. "We will do everything in our power to make this vaccine quickly and widely available," Soriot said.
4. Experts seek 'technical breakthrough' in scramble for rapid coronavirus tests
Fast, accessible, and reliable testing is key to containing the coronavirus pandemic, and experts are scrambling to develop "next-stage technologies" that could make such rapid tests widely available in the United States. OraSure Technologies says it's hoping to submit an at-home test to the FDA this September. There's also a Shark Tank-esque competition underway launched by the National Institutes of Health seeking to accelerate development of COVID-19 testing technologies, laying out an ambitious goal of making "millions of accurate and easy-to-use tests per week available to all Americans by the end of summer 2020." According to The Wall Street Journal, more than 280 groups have applied for the competition. But it's still an "open question" whether millions of rapid tests can be produced per week by the fall, the Journal notes. Quest Diagnostics' Gary Samuels said that it's "hard to imagine getting to the numbers that people are talking about without some sort of technical breakthrough, and that's what everyone's searching for."
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
5. CRISPR gene-editing tool could diagnose COVID-19 in 20 minutes
GlaxoSmithKline's consumer division is teaming up with California gene-editing startup Mammoth Biosciences to develop a rapid COVID-19 diagnostic test that could eventually be used at home. The test would use Mammoth's CRISPR gene-editing technology as a diagnostic tool, returning results from a nasal swab within 20 minutes. Eventually, the two companies want to make the tests available for consumers over the counter, but they will start in clinics and hospitals. "Using this CRISPR-based technology, you can actually create accurate tests, giving similar quality to what's in the lab but in a 'decentralized' format," said Mammoth CEO Trevor Martin. The companies expect to seek Food and Drug Administration emergency use authorization by the end of 2020.
Create an account with the same email registered to your subscription to unlock access.
-
All the records Taylor Swift has broken
Speed Read Swift's 'Eras' tour is now the highest-grossing concert tour in history
By Brendan Morrow Published
-
'Will growth slow, or is the economy about to fall off a cliff?'
Instant Opinion Opinion, comment and editorials of the day
By Harold Maass, The Week US Published
-
Senate passes FAA bill with new consumer protections
Speed Read The legislation will require airlines to refund customers for flight delays
By Peter Weber, The Week US Published
-
In what countries is assisted dying legal or under review?
In the spotlight More countries are granting more people the right to die
By Devika Rao, The Week US Published
-
Nigeria's worsening rate of maternal mortality
Under the radar Economic crisis is making hospitals unaffordable, with women increasingly not receiving the care they need
By Harriet Marsden, The Week UK Published
-
Dengue hits the Americas hard and early
Speed Read Puerto Rico has declared an epidemic as dengue cases surge
By Peter Weber, The Week US Published
-
How happy is Finland really?
Today's Big Question Nordic nation tops global happiness survey for seventh year in a row with 'focus on contentment over joy'
By Harriet Marsden, The Week UK Published
-
How Tehran became the world's nose job capital
Under the radar Iranian doctors raise alarm over low costs, weak regulation and online influence of 'Western beauty standards'
By Harriet Marsden, The Week UK Published
-
Africa's renewed battle against female genital mutilation
Under the radar Campaigners call for ban in Sierra Leone after deaths of three girls as coast-to-coast convoy prepares to depart
By Harriet Marsden, The Week UK Published
-
Argentina: the therapy capital of the world
Under the radar Buenos Aires natives go hungry to pay for psychoanalysis, amid growing instability, anxiety – and societal acceptance
By Harriet Marsden, The Week UK Published
-
Does declining birth rate spell doom for Britain?
Today's Big Question Ageing population puts pressure on welfare state, economy and fabric of society, while fertility is rising on populist agendas
By Harriet Marsden, The Week UK Published